Copyright Reports & Markets. All rights reserved.

Global and United States Respiratory Disease Testing/Diagnostics Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Respiratory Disease Testing/Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Imaging Test
    • 1.2.3 Respiratory Measurement
    • 1.2.4 Blood Gas Test
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Respiratory Disease Testing/Diagnostics Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Physician Clinics
    • 1.3.4 Clinical Laboratories
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Respiratory Disease Testing/Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Respiratory Disease Testing/Diagnostics Growth Trends by Regions
    • 2.2.1 Respiratory Disease Testing/Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Respiratory Disease Testing/Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Respiratory Disease Testing/Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Respiratory Disease Testing/Diagnostics Players by Market Size
    • 3.1.1 Global Top Respiratory Disease Testing/Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Respiratory Disease Testing/Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Respiratory Disease Testing/Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Respiratory Disease Testing/Diagnostics Revenue
  • 3.4 Global Respiratory Disease Testing/Diagnostics Market Concentration Ratio
    • 3.4.1 Global Respiratory Disease Testing/Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Respiratory Disease Testing/Diagnostics Revenue in 2019
  • 3.5 Key Players Respiratory Disease Testing/Diagnostics Area Served
  • 3.6 Key Players Respiratory Disease Testing/Diagnostics Product Solution and Service
  • 3.7 Date of Enter into Respiratory Disease Testing/Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Respiratory Disease Testing/Diagnostics Breakdown Data by Type (2015-2026)

  • 4.1 Global Respiratory Disease Testing/Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Respiratory Disease Testing/Diagnostics Forecasted Market Size by Type (2021-2026)

5 Respiratory Disease Testing/Diagnostics Breakdown Data by Application (2015-2026)

  • 5.1 Global Respiratory Disease Testing/Diagnostics Historic Market Size by Application (2015-2020)
  • 5.2 Global Respiratory Disease Testing/Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Respiratory Disease Testing/Diagnostics Market Size (2015-2026)
  • 6.2 North America Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
  • 6.3 North America Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
  • 6.4 North America Respiratory Disease Testing/Diagnostics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Respiratory Disease Testing/Diagnostics Market Size (2015-2026)
  • 7.2 Europe Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
  • 7.3 Europe Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
  • 7.4 Europe Respiratory Disease Testing/Diagnostics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Respiratory Disease Testing/Diagnostics Market Size (2015-2026)
  • 8.2 China Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
  • 8.3 China Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
  • 8.4 China Respiratory Disease Testing/Diagnostics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Respiratory Disease Testing/Diagnostics Market Size (2015-2026)
  • 9.2 Japan Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
  • 9.3 Japan Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
  • 9.4 Japan Respiratory Disease Testing/Diagnostics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Respiratory Disease Testing/Diagnostics Market Size (2015-2026)
  • 10.2 Southeast Asia Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Respiratory Disease Testing/Diagnostics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Becton Dickinson
    • 11.1.1 Becton Dickinson Company Details
    • 11.1.2 Becton Dickinson Business Overview
    • 11.1.3 Becton Dickinson Respiratory Disease Testing/Diagnostics Introduction
    • 11.1.4 Becton Dickinson Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020))
    • 11.1.5 Becton Dickinson Recent Development
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Company Details
    • 11.2.2 Abbott Laboratories Business Overview
    • 11.2.3 Abbott Laboratories Respiratory Disease Testing/Diagnostics Introduction
    • 11.2.4 Abbott Laboratories Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 11.2.5 Abbott Laboratories Recent Development
  • 11.3 Abbott
    • 11.3.1 Abbott Company Details
    • 11.3.2 Abbott Business Overview
    • 11.3.3 Abbott Respiratory Disease Testing/Diagnostics Introduction
    • 11.3.4 Abbott Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 11.3.5 Abbott Recent Development
  • 11.4 Cepheid
    • 11.4.1 Cepheid Company Details
    • 11.4.2 Cepheid Business Overview
    • 11.4.3 Cepheid Respiratory Disease Testing/Diagnostics Introduction
    • 11.4.4 Cepheid Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 11.4.5 Cepheid Recent Development
  • 11.5 Fischer and Paykel
    • 11.5.1 Fischer and Paykel Company Details
    • 11.5.2 Fischer and Paykel Business Overview
    • 11.5.3 Fischer and Paykel Respiratory Disease Testing/Diagnostics Introduction
    • 11.5.4 Fischer and Paykel Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 11.5.5 Fischer and Paykel Recent Development
  • 11.6 Futuremed
    • 11.6.1 Futuremed Company Details
    • 11.6.2 Futuremed Business Overview
    • 11.6.3 Futuremed Respiratory Disease Testing/Diagnostics Introduction
    • 11.6.4 Futuremed Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 11.6.5 Futuremed Recent Development
  • 11.7 Hoffmann-La Roche
    • 11.7.1 Hoffmann-La Roche Company Details
    • 11.7.2 Hoffmann-La Roche Business Overview
    • 11.7.3 Hoffmann-La Roche Respiratory Disease Testing/Diagnostics Introduction
    • 11.7.4 Hoffmann-La Roche Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 11.7.5 Hoffmann-La Roche Recent Development
  • 11.8 Instrumentation Laboratories
    • 11.8.1 Instrumentation Laboratories Company Details
    • 11.8.2 Instrumentation Laboratories Business Overview
    • 11.8.3 Instrumentation Laboratories Respiratory Disease Testing/Diagnostics Introduction
    • 11.8.4 Instrumentation Laboratories Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 11.8.5 Instrumentation Laboratories Recent Development
  • 11.9 Medtronic
    • 11.9.1 Medtronic Company Details
    • 11.9.2 Medtronic Business Overview
    • 11.9.3 Medtronic Respiratory Disease Testing/Diagnostics Introduction
    • 11.9.4 Medtronic Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 11.9.5 Medtronic Recent Development
  • 11.10 NDD Medical Technologies
    • 11.10.1 NDD Medical Technologies Company Details
    • 11.10.2 NDD Medical Technologies Business Overview
    • 11.10.3 NDD Medical Technologies Respiratory Disease Testing/Diagnostics Introduction
    • 11.10.4 NDD Medical Technologies Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 11.10.5 NDD Medical Technologies Recent Development
  • 11.11 Nihon Kohden
    • 10.11.1 Nihon Kohden Company Details
    • 10.11.2 Nihon Kohden Business Overview
    • 10.11.3 Nihon Kohden Respiratory Disease Testing/Diagnostics Introduction
    • 10.11.4 Nihon Kohden Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 10.11.5 Nihon Kohden Recent Development
  • 11.12 Philips Medical Systems
    • 10.12.1 Philips Medical Systems Company Details
    • 10.12.2 Philips Medical Systems Business Overview
    • 10.12.3 Philips Medical Systems Respiratory Disease Testing/Diagnostics Introduction
    • 10.12.4 Philips Medical Systems Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 10.12.5 Philips Medical Systems Recent Development
  • 11.13 SDI Diagnostics
    • 10.13.1 SDI Diagnostics Company Details
    • 10.13.2 SDI Diagnostics Business Overview
    • 10.13.3 SDI Diagnostics Respiratory Disease Testing/Diagnostics Introduction
    • 10.13.4 SDI Diagnostics Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 10.13.5 SDI Diagnostics Recent Development
  • 11.14 Seegene
    • 10.14.1 Seegene Company Details
    • 10.14.2 Seegene Business Overview
    • 10.14.3 Seegene Respiratory Disease Testing/Diagnostics Introduction
    • 10.14.4 Seegene Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 10.14.5 Seegene Recent Development
  • 11.15 Smiths Medical
    • 10.15.1 Smiths Medical Company Details
    • 10.15.2 Smiths Medical Business Overview
    • 10.15.3 Smiths Medical Respiratory Disease Testing/Diagnostics Introduction
    • 10.15.4 Smiths Medical Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
    • 10.15.5 Smiths Medical Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Respiratory Disease Testing/Diagnostics Scope and Market Size
    Respiratory Disease Testing/Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Disease Testing/Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Imaging Test
    Respiratory Measurement
    Blood Gas Test
    Other

    Market segment by Application, split into
    Hospitals
    Physician Clinics
    Clinical Laboratories
    Other

    Based on regional and country-level analysis, the Respiratory Disease Testing/Diagnostics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Respiratory Disease Testing/Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Becton Dickinson
    Abbott Laboratories
    Abbott
    Cepheid
    Fischer and Paykel
    Futuremed
    Hoffmann-La Roche
    Instrumentation Laboratories
    Medtronic
    NDD Medical Technologies
    Nihon Kohden
    Philips Medical Systems
    SDI Diagnostics
    Seegene
    Smiths Medical

    Buy now